According to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute, sexual impairment is common among men with chronic hepatitis C undergoing antiviral therapy.
This is the first time a study evaluating the combination therapy, peginterferon and ribavirin, has identified sexual dysfunction as a side effect. Sexual dysfunction and impairment of desire should be considered common side effects of combination antiviral therapy in men with hepatitis C. It has the potential to affect all three components of sexual health: desire, function and satisfaction.
No User Responded In This Post
Before Leave Your Comments Here Click Below On Our Sponsors...